結核治療中の結核免疫再構築炎症症候群
Melis Deniz1, Özge Kaba1, Ercan Ayaz2
1Department of Pediatric Infectious Diseases, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.
The American journal of tropical medicine and hygiene
|February 24, 2026
まとめ
HIV陰性の小児結核患者でも結核免疫再構築炎症症候群(TB-IRIS)を発症することがある。コルチコステロイド療法が、免疫能のある小児の症例に対して有効な治療法であった。
科学分野:
- 小児感染症; 免疫学; 肺病学
背景:
- 結核免疫再構築炎症症候群(TB-IRIS)は、結核治療を開始したHIV感染患者において知られている合併症である。免疫能のある小児患者におけるTB-IRISの発生は、依然として十分に理解されていない。
研究 の 目的:
- 肺結核を有する免疫能のある小児におけるTB-IRISの症例を報告する。この集団におけるTB-IRISの認識の重要性を強調する。
主な方法:
- 肺結核を有する免疫能のある小児の症例提示。抗結核療法中の臨床的および放射線学的モニタリング。コルチコステロイド治療への反応。
主要な成果:
- 患者は標準的な抗結核療法開始25日目に発熱、臨床的悪化、および新たな放射線学的病変を発症した。コルチコステロイド療法により、著明な臨床的改善と解熱が得られた。
結論:
- 他の原因を除外した後、結核治療後に新たなまたは悪化する症状および放射線学的所見を呈する結核を有する免疫能のある小児において、TB-IRISを考慮すべきである。早期認識とコルチコステロイドを含む適切な管理は、良好な転帰のために不可欠である。
さらに関連する動画
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
2.3K
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
19.4K
関連する概念動画
Pulmonary Tuberculosis I
1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Pulmonary Tuberculosis V
680
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
680
Pulmonary Tuberculosis IV
574
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
574
Pulmonary Tuberculosis II
1.7K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.7K
Pulmonary Tuberculosis III
1.2K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.2K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
602
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
602
